Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2018

20.07.2018 | Review

Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes

verfasst von: Mitsuo Terada, Yayoi Adachi, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Gondo Naomi, Haruru Kotani, Madoka Iwase, Ayumi Kataoka, Sakura Onishi, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Eiichi Sasaki, Yasushi Yatabe, Hiroji Iwata

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Occult breast cancer (OBC) is classified as a carcinoma of unknown primary, and involves axillary lymphadenopathy and is histologically consistent with metastatic breast cancer. OBC has been conventionally considered as a metastatic lymph node lesion, the origin of which is an undetectable breast tumor. Therefore, OBC patients would usually have undergone axillary lymph node dissection, and mastectomy or whole breast radiotherapy (WBRT). However, majority of OBC reports have been based on cases that were diagnosed during a period when diagnostics was still relatively primitive, and when magnetic resonance imaging was not yet a standard preoperative assessment. Therefore, there have been many false negatives in the breast based on preoperative assessment.

Methods

We herein hypothesize that the origin of OBC is ectopic breast tissue present in axillary lymph nodes (ALNs). If our hypothesis is true, mastectomy and WBRT may be unnecessary for OBC patients.

Results

Our hypothesis is supported by several findings. First, advances in radiological imaging have suggested that a primary breast tumor is absent in OBC patients. Second, proliferative breast lesions arising from ectopic breast present in ALNs have been reported. Lastly, cellular subtypes in OBC based on immunohistochemistry are of various types including ordinary breast cancer and the prognosis is not worse than stage II breast cancer.

Conclusion

It is important to distinguish between “primary” OBC in ALNs and “metastatic” OBC from micro-primary breast tumor. Further studies are required to determine if omission of mastectomy and WBRT is acceptable.
Literatur
1.
Zurück zum Zitat Baron PL, Moore MP, Kinne DW et al (1990) Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 125:210–214CrossRefPubMed Baron PL, Moore MP, Kinne DW et al (1990) Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 125:210–214CrossRefPubMed
3.
Zurück zum Zitat Patel J, Nemoto T, Rosner D et al (1981) Axillary lymph node metastasis from an occult breast cancer. Cancer 47:2923–2927CrossRefPubMed Patel J, Nemoto T, Rosner D et al (1981) Axillary lymph node metastasis from an occult breast cancer. Cancer 47:2923–2927CrossRefPubMed
4.
Zurück zum Zitat Rosen PP, Kimmel M (1990) Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 21:518–523CrossRefPubMed Rosen PP, Kimmel M (1990) Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 21:518–523CrossRefPubMed
7.
Zurück zum Zitat Edlow DW, Carter D (1973) Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol 59:666–673CrossRefPubMed Edlow DW, Carter D (1973) Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol 59:666–673CrossRefPubMed
8.
Zurück zum Zitat Turner DR, Millis RR (1980) Breast tissue inclusions in axillary lymph nodes. Histopathology 4:631–636CrossRefPubMed Turner DR, Millis RR (1980) Breast tissue inclusions in axillary lymph nodes. Histopathology 4:631–636CrossRefPubMed
9.
Zurück zum Zitat Maiorano E, Mazzarol GM, Pruneri G et al (2003) Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 27:513–518CrossRefPubMed Maiorano E, Mazzarol GM, Pruneri G et al (2003) Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 27:513–518CrossRefPubMed
12.
Zurück zum Zitat He M, Tang L-C, Yu K-D et al (2012) Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer. Eur J Surg Oncol 38:1022–1028CrossRefPubMed He M, Tang L-C, Yu K-D et al (2012) Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer. Eur J Surg Oncol 38:1022–1028CrossRefPubMed
15.
Zurück zum Zitat Blanchard DK, Farley DR (2004) Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg 28:535–539CrossRefPubMed Blanchard DK, Farley DR (2004) Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg 28:535–539CrossRefPubMed
16.
Zurück zum Zitat Vlastos G, Jean ME, Mirza AN et al (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8:425–431CrossRefPubMed Vlastos G, Jean ME, Mirza AN et al (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8:425–431CrossRefPubMed
18.
Zurück zum Zitat Ellerbroek N, Holmes F, Singletary E et al (1990) Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 66:1461–1467CrossRefPubMed Ellerbroek N, Holmes F, Singletary E et al (1990) Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 66:1461–1467CrossRefPubMed
19.
Zurück zum Zitat Merson M, Andreola S, Galimberti V et al (1992) Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer 70:504–508CrossRefPubMed Merson M, Andreola S, Galimberti V et al (1992) Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer 70:504–508CrossRefPubMed
20.
Zurück zum Zitat van Ooijen B, Bontenbal M, Henzen-Logmans SC, Koper PC (1993) Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg 80:1299–1300CrossRefPubMed van Ooijen B, Bontenbal M, Henzen-Logmans SC, Koper PC (1993) Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg 80:1299–1300CrossRefPubMed
21.
Zurück zum Zitat Foroudi F, Tiver KW (2000) Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys 47:143–147CrossRefPubMed Foroudi F, Tiver KW (2000) Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys 47:143–147CrossRefPubMed
24.
Zurück zum Zitat de Bresser J, de Vos B, van der Ent F, Hulsewé K (2010) Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 36:114–119CrossRefPubMed de Bresser J, de Vos B, van der Ent F, Hulsewé K (2010) Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 36:114–119CrossRefPubMed
25.
Zurück zum Zitat Kuroki-Suzuki S, Kuroki Y, Nasu K et al (2007) Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 6:21–27CrossRefPubMed Kuroki-Suzuki S, Kuroki Y, Nasu K et al (2007) Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 6:21–27CrossRefPubMed
26.
Zurück zum Zitat Malur S, Wurdinger S, Moritz A et al (2001) Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res BCR 3:55–60CrossRefPubMed Malur S, Wurdinger S, Moritz A et al (2001) Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res BCR 3:55–60CrossRefPubMed
39.
40.
Zurück zum Zitat van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC (1995) Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 63:790–793CrossRefPubMed van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC (1995) Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 63:790–793CrossRefPubMed
41.
Zurück zum Zitat Mori T, Morimoto T, Komaki K, Monden Y (1991) Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer. Cancer 68:532–537CrossRefPubMed Mori T, Morimoto T, Komaki K, Monden Y (1991) Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer. Cancer 68:532–537CrossRefPubMed
42.
Zurück zum Zitat Brunn Rasmussen B, Kamby C (1989) Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol Res Pract 185:856–859CrossRefPubMed Brunn Rasmussen B, Kamby C (1989) Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol Res Pract 185:856–859CrossRefPubMed
43.
Zurück zum Zitat Coradini D, Cappelletti V, Miodini P et al (1984) Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer. Tumori 70:165–168CrossRefPubMed Coradini D, Cappelletti V, Miodini P et al (1984) Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer. Tumori 70:165–168CrossRefPubMed
Metadaten
Titel
Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes
verfasst von
Mitsuo Terada
Yayoi Adachi
Masataka Sawaki
Masaya Hattori
Akiyo Yoshimura
Gondo Naomi
Haruru Kotani
Madoka Iwase
Ayumi Kataoka
Sakura Onishi
Kayoko Sugino
Makiko Mori
Nanae Horisawa
Eiichi Sasaki
Yasushi Yatabe
Hiroji Iwata
Publikationsdatum
20.07.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4898-4

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research and Treatment 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.